Drug Type T-lymphocyte cell therapy |
Synonyms |
Target- |
Mechanism Immunologic cytotoxicity, T lymphocyte replacements |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Cervical Carcinoma | Phase 1 | CN | 01 Jul 2022 | |
Metastatic Carcinoma to the Uterine Cervix | Phase 1 | CN | 01 Jul 2022 |